Unraveling SARS-CoV-2 spike protein activation pathway reveals unprecedented cryptic pockets
Unraveling SARS-CoV-2 spike protein activation pathway reveals unprecedented cryptic pockets
复制标题
DOI:
10.1016/j.bpj.2021.11.491
复制
发表时间:
2022-02-11
影响因子:
3.4
通讯作者:
Sugita Y
中科院分区:
文献类型:
--
作者:
Dokainish HM;Re S;Mori T;Kobayashi C;Jung J;Sugita Y
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents an immediate threat to global health. Spike (S) protein on the surface of SARS-CoV-2 has been recognized as a primary antigenic target for viral neutralization and vaccine development. S-protein consists of trimeric polypeptide chains heavily glycosylated and undergoes large conformational changes of its receptor binding domain (RBD) during the activation. Structural studies have shown more than 300 S-protein conformations, which include inactive down, one-RBD-up (one-up), two-RBDs-up (two-up), and three-RBDs-up (three-up) states, while little is known about the intermediate structures and mechanisms of the structural transitions. Here, we performed atomistic molecular dynamics (MD) simulations based on an enhanced conformational sampling method to explore a wide conformational space of S-protein in solution. Starting from either down or one-up cryo-EM structures, we observed multiple transitions between down, one-up, one-open, and two-up-like conformations, suggesting the intrinsic flexibility and dynamics of RBDs of S-protein regardless of its binding to antibodies or ACE2 receptor in human host cells. Three key glycans attached at N165, N234, N343 play essential roles in the structural transitions. Larger conformational fluctuations were observed in the simulations of S-protein and a monomeric S-protein without glycosylation, suggesting that the glycans greatly reduce the number of available conformations of S-protein. As consistent with single-molecule FRET experiments, two intermediate structures between down and one-up were found and they reveal unprecedented cryptic pockets that might be targeted to stabilize down conformation, hindering ACE2 binding and subsequently cell entry o. Modelling S-protein and different classes of antibodies interactions shows that glycan shielding is the weakest in one-open conformation. Indeed, such inherent dynamics and flexibility of S-protein shall be considered for rational design of antiviral drugs and vaccine developments.